Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

ConclusionsTaken together, this dataset will provide a framework for characterization and enable the selection of the optimal models for immunotherapy combinations and generate potential biomarkers for clinical evaluation in identifying responders and non-responders to immunotherapy combinations.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research